Picture of dr Zico Paradigma
Mastopexy in Management of Gynecomastia in Kallman Syndrome (Case Report)
by dr Zico Paradigma - Sunday, 2 September 2018, 08:54 AM
Gynaecomastia is defined as a benign enlargement of the male breast. It is a common condition, with a prevalence in young patients as high as 38%. The condition may be caused by an increase in the effective oestrogen–testosterone ratio, which can be either physiological or pathological. In most cases of physiological gynaecomastia reassurance is all that is needed. Treatment of any underlying cause is important, but may fail to resolve the breast development, especially if it has been present for some time. Specific treatment of the enlarged breast is indicated if the gynaecomastia causes sufficient pain, embarrassment or emotional discomfort to interfere with the patient’s daily life. The two treatment options are medical therapy and surgical removal. Medical therapy is probably most effective during the active proliferative phase of gynaecomastia. Danazol, clomiphene, testolactone and tamoxifen have been used. If a trial period of medical therapy is unsuccessful or if the gynaecomastia has been present for several years and is bothersome to the patient, then the breast glandular tissue should be removed surgically.

Link fulltext:


Nama         : Danar Widyatmoko, dr
Judul          : Mastopexy in Management of Gynecomastia in Kallman Syndrome (Case Report)

Pembimbing :
Dr. Kristanto Yuli Yarsa, dr., SpB(K)Onk

Hari/Tanggal : Senin, 03 September 2018
Jam                 : 08.30 WIB
Tempat           : Ruang Pertemuan Bedah Anggrek IV

Penanya Wajib :
1. Tegoeh Winandar, dr
2. Alfian Fahmi, dr
3. Bagus Aris Madani, dr